News, Resources, & Updates

Disclosing Relationships with Influencers on Social Media

By Deborah Kelly, public relations manager, Boiron USA March 1, 2017 The core mission of the Federal Trade Commission (FTC) is to regulate advertising so...

Outlook 2017

By Mark Land, AAHP President March 1, 2017 2017 is shaping up to be a year in motion—both for our industry and our country. With...

The FTC and the Web

By Alvin J. Lorman, Association Counsel March 1, 2017 The recent claim by the Federal Trade Commission (FTC) that its policy statement on marketing of...

Manufacturers of Homeopathic Medicines Review FDA Test Results and New Application of Technology

MILWAUKIE, Ore., Feb. 14, 2017 — The U.S. Food and Drug Administration (FDA) announced on Jan. 27 that its laboratory analysis found inconsistent levels of...

AAHP in 2016 and a Review of New Member Resources

Jan. 26, 2017 In 2016, the Education Committee produced four robust webinars, and industry leaders united at two membership meetings. As we step forward into...

The Tale of the Contract Manufacturer: A Story Based on an AAHP Member Question

By Eric Foxman, AAHP Secretary Once upon a time, a special creature, the CIAMP (Company Interested in Alternative Medical Products), wanted Phoxman Farmaceuticals (PhoxFarm) to...

Congress to Tackle “Must Pass” FDA Legislation Next Year

The Prescription Drug User Fee Act (PDUFA) authorizes the Food and DrugAdministration (FDA) to collect fees from Rx pharmaceutical companies to help fund the agency's...

What About Your APIs and Q7 Requirements?

By Eric L. Foxman, R.Ph. Jan. 26, 2017 In September 2016, the U.S. Food and Drug Administration (FDA) issued a guidance document, entitled Q7 Good...

The European Pharmacopeia and How U.S. Manufacturers Can Use It

By Mark S. Phillips, Pharm. D. Jan. 26, 2017 On Jan. 1, 2017, the 9th edition of the European Pharmacopoeia (Ph. Eur.) became legally binding...